Regulating Private Equity in Clinical Care Delivery—Lessons From California and Oregon

Key Points

• This viewpoint aims to analyze the regulatory frameworks surrounding private equity in clinical settings.
• Examination of corporate practice of medicine doctrines
• Analysis of regulatory limitations and exemptions
• Discussion of policy implications in California and Oregon
• Identified key regulatory frameworks affecting private equity
• Highlighted limitations and exemptions in clinical care
• Discussed implications for the corporate practice of medicine